Palmer Dupeh R, Fernandez Stefan, Bisbing John, Peachman Kristina K, Rao Mangala, Barvir Dave, Gunther Vicky, Burgess Timothy, Kohno Yukari, Padmanabhan R, Sun Wellington
Department of Virus Diseases, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
Division of Retrovirology, Walter Reed Army Institute of Research, Rockville, MD, USA.
J Gen Virol. 2007 Jan;88(Pt 1):148-156. doi: 10.1099/vir.0.82272-0.
The yellow fever virus attenuated 17D vaccine strain is a safe and effective vaccine and a valuable model system for evaluating immune responses against attenuated viral variants. This study compared the in vitro interactions of the commercially available yellow fever vaccine (YF-VAX), Dengue virus and the live-attenuated dengue vaccine PDK50 with dendritic cells (DCs), the main antigen-presenting cells at the initiation of immune responses. Similar to PDK50, infection with YF-VAX generated activated DCs; however, for YF-VAX, activation occurred with limited intracellular virus replication. The majority of internalized virus co-localized with endolysosomal markers within 90 min, suggesting that YF-VAX is processed rapidly in DCs. These results indicate that restricted virus replication and lysosomal compartmentalization may be important contributing factors to the success of the YF-VAX vaccine.
黄热病病毒减毒17D疫苗株是一种安全有效的疫苗,也是评估针对减毒病毒变体免疫反应的宝贵模型系统。本研究比较了市售黄热病疫苗(YF-VAX)、登革病毒和减毒活登革疫苗PDK50与树突状细胞(DCs)的体外相互作用,DCs是免疫反应启动时的主要抗原呈递细胞。与PDK50相似,YF-VAX感染可产生活化的DCs;然而,对于YF-VAX,活化发生时细胞内病毒复制有限。大多数内化病毒在90分钟内与内溶酶体标记物共定位,这表明YF-VAX在DCs中被快速处理。这些结果表明,受限的病毒复制和溶酶体区室化可能是YF-VAX疫苗成功的重要促成因素。